Dow Up 0.51% Nasdaq Up 0.24%

Keryx Biopharmaceuticals Inc. (KERX)

-NasdaqCM
15.70 Up 0.17(1.09%) Nov 21, 4:00PM EST
|After Hours : 15.72 Up 0.02 (0.13%) Nov 21, 7:48PM EST
Prev Close:15.53
Open:15.75
Bid:15.52 x 100
Ask:N/A
1y Target Est:23.58
Beta:6.55
Next Earnings Date:N/A
Day's Range:15.69 - 16.15
52wk Range:11.53 - 18.48
Volume:1,068,342
Avg Vol (3m):2,451,320
Market Cap:1.44B
P/E (ttm):N/A
EPS (ttm):-1.00
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
KERXUp 1.09%1.44B
BAXUp 0.63%39.26B
SHPGDown 0.54%41.15B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):139.22
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.16
Quarterly EPS Est (Dec-14) :-0.37
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):-0.45

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of pharmaceutical products for the treatment of renal disease in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback